Journal List > Korean J Lab Med > v.28(2) > 1011454

Shin, Jin, and Stroncek: Effect of Leukapheresis on Gene Expression Profiles of Donor's Peripheral Blood Mononuclear Cells

Abstract

Background

Leukapheresis has commonly been used to obtain the cell products intended for clinical cell therapy. Hypocalcemia related to citrate toxicity and some circulatory effects such as hypovolemia and hypotension are well-known complications of leukapheresis. In this study, we analyzed the gene expression profiles of peripheral blood mononuclear cells (PBMCs) obtained before and after leukapheresis to determine if the hemodynamic changes can affect the gene expression profiles of leukocytes.

Methods

PBMCs were isolated from EDTA blood from 5 healthy donors collected before and immediately after apheresis. RNA was isolated, amplified, and analyzed using a cDNA microarray with 17,500 genes. Hierarchical clustering analysis was performed to evaluate the differences of gene expression profiling.

Results

Hierarchical clustering separated PBMCs from different donors with each other, but did not separate PBMCs collected before and after leukapheresis. Comparison of gene expression by PBMCs collected before and after leukapheresis found only 25 genes were differentially expressed (15 were up-regulated and 10 were down-regulated after leukapheresis) (F-test, P<0.005). Stress induced apoptosis-related genes, ANXA3, DEDD, and ATXN2L, and cytokine-related genes, IL13RA1 and IK, which were also related to stress, were up-regulated after leukapheresis. Genes involved in DNA and protein binding, such as CLSTN3, LRBA, SATB2, and HSPA8, were down-regulated.

Conclusions

Leukapheresis had little effect on gene expression of PBMCs. Some genes showing differences between before and after leukapheresis were mainly involved in stress-related reactions.

REFERENCES

1.Hashimoto SI., Suzuki T., Nagai S., Yamashita T., Toyoda N., Matsushima K. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood. 2000. 96:2206–14.
crossref
2.Dauer M., Obermaier B., Herten J., Haerle C., Pohl K., Rothenfusser S, et al. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J Immunol. 2003. 170:4069–76.
crossref
3.Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994. 194:1109–18.
crossref
4.Felzmann T., Witt V., Wimmer D., Ressmann G., Wagner D., Paul P, et al. Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection. Cytotherapy. 2003. 5:391–8.
crossref
5.Han KS, Park MH, editors. Transfusion medicine. 2nd ed.Seoul: Korea Medical Book Publisher Co;1999. p. 10. (한규섭, 박명희, 등. 수혈의학. 제2판. 서울: 고려의학 1999 10).
crossref
6.Brecher ME, editor. Technical manual. 15th ed.Bethesda: American Association of Blood Banks;2005. p. 587.
7.Ottinger HD., Beelen DW., Scheulen B., Schaefer UW., Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood. 1996. 88:2775–9.
crossref
8.Whang DH., Hur M., Park KU., Shin S., Kim YH., Shin HY, et al. Experience with 671 peripheral blood stem cell collection. Korean J Blood Transfus. 2000. 11:145–56. (황동희, 허미나, 박경운, 신수, 김양현, 신희영등. 말초혈액조혈모세포채집술 671예시행경험. 대한수혈학회지 2000;11: 145-56.).
9.Wang E., Miller LD., Ohnmacht GA., Liu ET., Marincola FM. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol. 2000. 18:457–9.
crossref
10.Wang E., Miller LD., Ohnmacht GA., Mocellin S., Perez-Diez A., Petersen D, et al. Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res. 2002. 62:3581–6.
11.Eisen MB., Spellman PT., Brown PO., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998. 95:14863–8.
crossref
12.Han J., Farnsworth RL., Tiwari JL., Tian J., Lee H., Ikonomi P, et al. Quality prediction of cell substrate using gene expression profiling. Genomics. 2006. 87:552–9.
crossref
13.Park BJ., Kim GK. Gene expression profiling of meningioma by cDNA chip. J Korean Neurosurg Soc. 2004. 35:560–8. (박봉진 및 김국기. 수막종에서cDNA chip을이용한유전자발현연구. J Korean Neurosurg Soc 2004;35: 560-8.).
14.Baechler EC., Batliwalla FM., Karypis G., Gaffney PM., Moser K., Ortmann WA, et al. Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun. 2004. 5:347–53.
crossref
15.Ng H., Pulst SM., Huynh DP. Ataxin-2 mediated cell death is dependent on domains downstream of the polyQ repeat. Exp Neurol. 2007. 208:207–15.
crossref
16.Wiedemeyer R., Westermann F., Wittke I., Nowock J., Schwab M. Ataxin-2 promotes apoptosis of human neuroblastoma cells. Oncogene. 2003. 22:401–11.
crossref
17.Kim YM., Kim HJ., Song EJ., Lee KJ. Glucuronic acid is a novel inducer of heat shock response. Mol Cell Biochem. 2004. 259:23–33.
18.Mehta J., Singhal S., Gordon L., Tallman M., Williams S., Luyun R, et al. Cobe Spectra is superior to Fenwal CS 3000 Plus for collection of hematopoietic stem cells. Bone Marrow Transplant. 2002. 29:563–7.
crossref
19.Ford CD., Lehman C., Strupp A., Kelley L. Comparison of CD34+ cell collection efficiency on the COBE Spectra and Fenwal CS-3000 Plus. J Clin Apher. 2002. 17:17–20.
crossref

Fig. 1.
Gene expression profiles of PBMCs obtained before and after leukapheresis. The 8,661 genes that remained after filtering (expressed in 80% of samples) were analyzed. Hierarchical clustering separated PBMCs from different donors with each other, but did not separate PBMCs collected before and after leukapheresis. Pre-PBMC, PBMCs obtained before leukapheresis; Post-PBMC, PBMCs obtained after leukapheresis.
kjlm-28-130f1.tif
Table 1.
Characteristics of donors and samples
Donor No Age Sex Race Cell separator Product volume Cell counts of products
Hb (g/dL) WBC (× 103/μL) PLT (× 103/L)
pre post pre post pre post
1 48 F African-American Cobe Spectra 136 mL 11.9 11.0 4.8 4.5 275 174
2 68 M Caucasian Cobe Spectra 128 mL 13.6 13.6 5.4 5.7 196 135
3 32 M African-American CS3000 136 mL 14.5 14.1 3.8 3.4 244 176
4 29 M Hispanic Cobe Spectra 137 mL 14.3 14.6 6.1 5.7 281 218
5 56 M Caucasian Cobe Spectra 150 mL 15.0 15.0 4.5 4.4 239 156

PBMCs obtained before leukapheresis;

PBMCs obtained after leukapheresis.

Table 2.
Genes differentially expressed by post-leukapheresis PBMCs compared to pre-leukapheresis PBMCs
  Genes Descriptions Fold changes Functions involved
Up-regulated genes (15) ANXA3 Annexin A3 4.4 Apoptosis
        Inhibitor of phospholipase A2
  CREB1 CAMP responsive element binding protein 1 2.9 Transcription activator
  DEDD Death effector domain containing 2.9 Apoptosis
  ATXN2L Ataxin 2-like 2.6 Apoptosis
  SLC6A3 Solute carrier family 6 2.5 Transcription
        Membrane transport
  MLANA Melan-A 2.4 Metabolism
  GRLF1 Glucocorticoid receptor DNA binding factor 1 2.3 Transcription suppressor
  IL13RA1 Interleukin 13 receptor alpha 1 2.2 Cytokine
  IK IK cytokine down-regulator of HLA II 2.2 Cytokine
  RFXANK Regulatory factor X-associated ankyrin-containing protein 1.9 Transcription activator
  GPR56 G protein-coupled receptor 1.9 Cell-to-cell interactions
  RGS14 Regulator of G-protein signaling 14 1.8 Signal transduction inhibitor
  NR2F6 Nuclear receptor subfamily 2 group F, member 6 1.8 Transcription activator
  KNS2 Kinesin 2 1.7 Nucleotide/ATP binding
  NARF Nuclear prelamin A recognition factor 1.7 Iron/protein binding
Down-regulated genes (10) CLSTN3 Calsyntenin 3 -3.1 Calcium ion/protein binding
  LRBA LPS-responsive vesicle trafficking -2.7 Protein binding
  ANKRD50 Ankyrin repeat domain 50 -2.2 Transcription suppressor
  SATB2 SATB family member 2 -2.2 DNA binding
  MAPK2 Mitogen-activated protein kinase 2 -1.9 Apoptosis/anti-Apoptosis, Stress response
  HSPA8 Heat shock 70kDa protein 8 -1.8 Nucleotide/ATP binding
  NMB Neuromedin B -1.8 Hormone activity
  EPS8L1 EPS8-like 1 -1.7 Membrane remodeling of the actin cytoskeleton
  GAB2 GRB2-associated binding protein 2 -1.6 Protein binding
  PPP2R5C Protein phosphatase 2, regulatory subunit B, gamma isoform -1.5 Peptidase activity
TOOLS
Similar articles